SCHEMBL5560757

SCHEMBL5560757

COc1cc2c(Oc3cc(CCC4CCCC4)[nH]n3)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.51
EGFR P00533 7/20 0.49
SRC P12931 5/20 0.49
KDR P35968 5/20 0.49
AXL P30530 3/20 0.49
FLT3 P36888 3/20 0.49
FLT4 P35916 3/20 0.49
KIT P10721 3/20 0.49
MERTK Q12866 2/20 0.49
AURKA O14965 2/20 0.49
GAK O14976 2/20 0.49
EPHB6 O15197 2/20 0.49
RIPK2 O43353 2/20 0.49
STK10 O94804 2/20 0.49
MAP4K4 O95819 2/20 0.49
CHEK2 O96017 2/20 0.49
ABL1 P00519 2/20 0.49
ERBB2 P04626 2/20 0.49
LCK P06239 2/20 0.49
LYN P07948 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5567176 0.89 KDM1A (0.55) KDM1AEGFRSRCKDRAXL
SCHEMBL5566463 0.88 AURKA (0.58) KDM1AEGFRSRCKDRAXL
SCHEMBL5566275 0.87 KDM1A (0.57) KDM1AEGFRSRCKDRAXL
SCHEMBL5567304 0.87 KDM1A (0.57) KDM1AEGFRSRCKDRAXL
SCHEMBL5560438 0.86 KDM1A (0.53) KDM1AEGFRSRCKDRAXL
SCHEMBL5566886 0.86 KDM1A (0.53) KDM1AEGFRSRCKDRAXL
SCHEMBL5562087 0.85 SRC (0.55) KDM1AEGFRSRCKDRAXL
SCHEMBL5566389 0.85 KDM1A (0.55) KDM1AEGFRSRCKDRAXL
SCHEMBL5564985 0.83 SRC (0.55) KDM1AEGFRSRCKDRFLT4
SCHEMBL5565947 0.80 KDR (0.55) KDM1AEGFRSRCKDRAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 US disclosed
EP-1119567-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-05-04 EP disclosed
EP-1119567-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2001-08-01 EP disclosed
WO-2000021955-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-04-20 WO disclosed